IOL Chemicals and Pharmaceuticals Q3 FY23 income down 6%
The company completed paracetamol capacity expansion by 1,800 MTPA and the company is now focusing on frugal manufacturing practices to reduce raw material cost and expand margins
The company completed paracetamol capacity expansion by 1,800 MTPA and the company is now focusing on frugal manufacturing practices to reduce raw material cost and expand margins
Net sales for 9M FY23 up 9% to Rs. 4,246 crore and net profit for 9M FY23 at Rs. 189 crore
The company has reported total income of Rs.77.0791 crores during the period ended December 31, 2022 as compared to Rs.69.9191 crores during the period ended December 31, 2021.
For discovery or for standardization, Ayurveda colleges/institutes need to collaborate closely with Phytochemists, Pharmacologists, and Toxicologists from premier institutions
With the on-going relentless efforts to imbibe new developments in ART, India will make significant progress in ensuring the best facilities and care for fertility to couples in India
The agreement between Eli Lilly and Janssen was established to allow the two companies to share resources for the goal of accelerating the evaluation of the respective companies’ assets, mirikizumab and Tremfya (guselkumab).
Company has provided Image Transmission and Reporting of Radiology Images and Selective Radiology Services (X-ray Tele Radiology Services) across all districts in the state of Tripura during the month of June, 2022 and operationalized its services at all the allocated places as on date.
The company has reported total income of Rs. 781.40 crores during the period ended December 31, 2022
Theramex were searching for a platform to digitise the manual processes across their R&D landscape
The company has posted net profit of Rs. 475.94 crores for the period ended December 31, 2022
Subscribe To Our Newsletter & Stay Updated